TB and interstitial lung disease : a systematic review and meta-analysis
<sec id="st1"><title>INTRODUCTION</title>To determine the frequency of TB among patients with interstitial lung diseases (ILDs).</sec><sec id="st2"><title>METHODS</title>We performed a comprehensive search in the PubMed/Medline, EMBASE and Scopus databases up to 1 August 2023 of studies reporting on the prevalence of TB among patients with ILDs.</sec><sec id="st3"><title>RESULTS</title>Twelve studies comprising 3,817 patients with ILD were found: the pooled prevalence of TB among ILD patients was 11.0% (95% CI 5.4-21.0). In the subgroup analysis, the TB rate among patients with silicosis and idiopathic pulmonary fibrosis (IPF) was respectively 35.6% (95% CI 32.6-38.8) and 4.4% (95% CI 3.6-5.3) (P = 0.00). The frequency of TB among ILD patients was higher in high TB burden countries than in low/intermediate-burden countries: 26.3%, 95% CI 17.7-37.3 vs. 4.9%, 95% CI 3.3-7.2; P = 0.00.</sec><sec id="st4"><title>CONCLUSIONS</title>This study shows the frequency of TB among ILD patients. The meta-analysis reveals a significantly increased prevalence of TB among ILD patients with silicosis compared to IPF, and among individuals in high TB burden countries than in those with low/intermediate burden. The study results can help physicians and policymakers make efficient decisions for prompt screening and anti-TB treatment initiation in ILD patients.</sec>.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - volume:28 |
---|---|
Enthalten in: |
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease - 28(2024), 3 vom: 01. März, Seite 130-135 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Rezaee, M [VerfasserIn] |
---|
Links: |
---|
Themen: |
---|
Anmerkungen: |
Date Completed 11.03.2024 Date Revised 11.03.2024 published: Print Citation Status MEDLINE |
---|
doi: |
10.5588/ijtld.23.0428 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM369439244 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM369439244 | ||
003 | DE-627 | ||
005 | 20240311232614.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240308s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.5588/ijtld.23.0428 |2 doi | |
028 | 5 | 2 | |a pubmed24n1323.xml |
035 | |a (DE-627)NLM369439244 | ||
035 | |a (NLM)38454180 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Rezaee, M |e verfasserin |4 aut | |
245 | 1 | 0 | |a TB and interstitial lung disease |b a systematic review and meta-analysis |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 11.03.2024 | ||
500 | |a Date Revised 11.03.2024 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a <sec id="st1"><title>INTRODUCTION</title>To determine the frequency of TB among patients with interstitial lung diseases (ILDs).</sec><sec id="st2"><title>METHODS</title>We performed a comprehensive search in the PubMed/Medline, EMBASE and Scopus databases up to 1 August 2023 of studies reporting on the prevalence of TB among patients with ILDs.</sec><sec id="st3"><title>RESULTS</title>Twelve studies comprising 3,817 patients with ILD were found: the pooled prevalence of TB among ILD patients was 11.0% (95% CI 5.4-21.0). In the subgroup analysis, the TB rate among patients with silicosis and idiopathic pulmonary fibrosis (IPF) was respectively 35.6% (95% CI 32.6-38.8) and 4.4% (95% CI 3.6-5.3) (P = 0.00). The frequency of TB among ILD patients was higher in high TB burden countries than in low/intermediate-burden countries: 26.3%, 95% CI 17.7-37.3 vs. 4.9%, 95% CI 3.3-7.2; P = 0.00.</sec><sec id="st4"><title>CONCLUSIONS</title>This study shows the frequency of TB among ILD patients. The meta-analysis reveals a significantly increased prevalence of TB among ILD patients with silicosis compared to IPF, and among individuals in high TB burden countries than in those with low/intermediate burden. The study results can help physicians and policymakers make efficient decisions for prompt screening and anti-TB treatment initiation in ILD patients.</sec> | ||
650 | 4 | |a Meta-Analysis | |
650 | 4 | |a Systematic Review | |
650 | 4 | |a Journal Article | |
700 | 1 | |a Azizi, N |e verfasserin |4 aut | |
700 | 1 | |a Danaei, B |e verfasserin |4 aut | |
700 | 1 | |a Davari, A |e verfasserin |4 aut | |
700 | 1 | |a Nejadghaderi, S A |e verfasserin |4 aut | |
700 | 1 | |a Sarmastzadeh, T |e verfasserin |4 aut | |
700 | 1 | |a Rahmannia, M |e verfasserin |4 aut | |
700 | 1 | |a Khalili, F |e verfasserin |4 aut | |
700 | 1 | |a Shahidi-Bonjar, A H |e verfasserin |4 aut | |
700 | 1 | |a Centis, R |e verfasserin |4 aut | |
700 | 1 | |a D'Ambrosio, L |e verfasserin |4 aut | |
700 | 1 | |a Sotgiu, G |e verfasserin |4 aut | |
700 | 1 | |a Migliori, G B |e verfasserin |4 aut | |
700 | 1 | |a Nasiri, M J |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease |d 1998 |g 28(2024), 3 vom: 01. März, Seite 130-135 |w (DE-627)NLM093757409 |x 1815-7920 |7 nnns |
773 | 1 | 8 | |g volume:28 |g year:2024 |g number:3 |g day:01 |g month:03 |g pages:130-135 |
856 | 4 | 0 | |u http://dx.doi.org/10.5588/ijtld.23.0428 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 28 |j 2024 |e 3 |b 01 |c 03 |h 130-135 |